Published in J Clin Immunol on January 01, 1998
Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med (1998) 3.50
Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J Exp Med (1999) 1.58
Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol (2007) 1.42
Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci U S A (2001) 1.21
In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci (2004) 1.13
CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut (2005) 1.06
TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis. Clin Exp Immunol (2003) 1.06
Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria. Clin Diagn Lab Immunol (2000) 1.02
Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology (2008) 1.00
Heat shock proteins induce T cell regulation of chronic inflammation. Ann Rheum Dis (2006) 0.98
Suppression of Th1 and Th17, but not Th2, responses in a CD8(+) T cell-mediated model of oral tolerance. Mucosal Immunol (2009) 0.94
The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease. J Clin Invest (2001) 0.93
Tolerance and bystander suppression, with involvement of CD25-positive cells, is induced in rats receiving serum from ovalbumin-fed donors. Immunology (2000) 0.86
Staphylococcal enterotoxins in the etiopathogenesis of mucosal autoimmunity within the gastrointestinal tract. Toxins (Basel) (2014) 0.86
Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease. Dig Dis Sci (2008) 0.86
Bacterial translocation and immunohistochemical measurement of gut immune function. J Clin Pathol (2001) 0.82
Functional transforming growth factor-β receptor type II expression by CD4+ T cells in Peyer's patches is essential for oral tolerance induction. PLoS One (2011) 0.79
Are we getting enough allergens? Int Arch Allergy Immunol (2008) 0.78
Lamina propria lymphocytes produce interferon-gamma and develop suppressor activity in response to lactoglobulin. Dig Dis Sci (2001) 0.75
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69
Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol (1994) 8.43
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity (1994) 7.22
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med (1996) 6.73
Inflammatory bowel disease (1) N Engl J Med (1991) 5.78
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A (1992) 4.94
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med (1994) 4.10
Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med (1996) 4.09
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity (1997) 4.05
Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol (1984) 3.89
Systemic tolerance and secretory immunity after oral immunization. J Exp Med (1980) 3.79
Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature (1995) 3.46
Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol (1995) 2.87
Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J Immunol (1978) 2.86
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A (1994) 2.82
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A (1991) 2.72
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68
Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science (1994) 2.66
Antigen-driven bystander suppression after oral administration of antigens. J Exp Med (1991) 2.62
Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med (1997) 2.59
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol (1988) 2.59
Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol (1991) 2.46
Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today (1997) 2.44
Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol (1977) 2.40
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol (1997) 2.35
Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut (1995) 2.29
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest (1996) 2.27
Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A (1986) 2.27
Enterically induced immunologic tolerance. I. Induction of suppressor T lymphoyctes by intragastric administration of soluble proteins. J Immunol (1978) 2.17
Oral tolerance. Transplantation (1980) 2.17
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol (1990) 2.13
Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci U S A (1996) 2.06
Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med (1996) 2.06
Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell (1993) 1.99
Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology (1983) 1.99
Functional characteristics of Peyer's patch lymphoid cells. I. Induction of humoral antibody and cell-mediated allograft reactions. J Exp Med (1974) 1.76
Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol (1991) 1.75
Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol (1994) 1.72
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol (1997) 1.71
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis (1996) 1.68
Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol (1995) 1.63
Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J Exp Med (1988) 1.63
Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J Immunol (1998) 1.56
CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J Immunol (1991) 1.54
Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med (1996) 1.50
High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol (1996) 1.49
Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol (1986) 1.49
Orally induced tolerance. Definition at the cellular level. Int Arch Allergy Appl Immunol (1981) 1.48
Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol (1993) 1.47
Oral tolerance to ovalbumin in mice: studies of chemically modified and 'biologically filtered' antigen. Immunology (1986) 1.46
CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology (1997) 1.44
Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol (1997) 1.40
Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol (1997) 1.39
Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci U S A (1996) 1.38
Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med (1997) 1.36
Immunological responses to fed protein antigens in mice. IV. Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin. Immunology (1983) 1.35
The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology (1986) 1.33
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol (1990) 1.29
Effects of antigen-feeding on intestinal and systemic immune responses. II. Suppression of delayed-type hypersensitivity reactions. J Immunol (1978) 1.29
Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol (1993) 1.29
Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol (1995) 1.27
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann Neurol (1991) 1.23
Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol (1996) 1.22
Lack of oral tolerance in C3H/HeJ mice. J Exp Med (1982) 1.19
The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol (1990) 1.19
Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J Immunol (1982) 1.19
Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol (1996) 1.17
The regulation of immune responses to dietary protein antigens. Immunol Today (1987) 1.15
T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol (1995) 1.14
Depletion of suppressor T cells by 2'-deoxyguanosine abrogates tolerance in mice fed ovalbumin and permits the induction of intestinal delayed-type hypersensitivity. Immunology (1986) 1.14
Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch. Cell Immunol (1981) 1.14
Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment. J Immunol (1990) 1.13
Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest (1996) 1.11
Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial. Arthritis Rheum (1996) 1.09
Regulation of transforming growth factor-beta production by interleukin-12. Eur J Immunol (1997) 1.09
A role for CD4 in peripheral T cell differentiation. J Exp Med (1997) 1.08
TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J Immunol (1997) 1.04
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. J Neuroimmunol (1993) 1.02
In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann N Y Acad Sci (1996) 1.01
Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med (1997) 1.00
Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology (1987) 0.99
A genetically determined lack of oral tolerance to ovalbumin is due to failure of the immune system to respond to intestinally derived tolerogen. Eur J Immunol (1987) 0.98
Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice. Immunology (1986) 0.97
Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice. Gut (1986) 0.96
Immunosuppression caused by antigen feeding II. Suppressor T cells mask Peyer's patch B cell priming to orally administered antigen. Eur J Immunol (1983) 0.96
Kinetics of oral tolerance: study of variables affecting tolerance induced by oral administration of antigen. Int Arch Allergy Appl Immunol (1984) 0.95
Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology (1988) 0.94
Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation (1992) 0.93
The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens. Gastroenterology (1976) 0.93
Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol (1996) 0.91
The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1. Ann N Y Acad Sci (1996) 0.91
Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann N Y Acad Sci (1996) 0.91
Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol Lett (1995) 0.90
Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today (1997) 2.52
Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10
Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J Immunol (1998) 1.56
An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci (1994) 1.02
Treatment of refractory Whipple disease with interferon-gamma. Ann Intern Med (1998) 0.93
[S2k-guideline gastrointestinal infectious diseases and Whipple's disease]. Z Gastroenterol (2015) 0.85
Limited role for PCR-based diagnosis of Whipple's disease from peripheral blood mononuclear cells. Lancet (1996) 0.85
Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease. Int J Colorectal Dis (2005) 0.84
-295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease. Eur J Clin Microbiol Infect Dis (2015) 0.84
Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot study. BMC Infect Dis (2001) 0.83
Effect of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice. Ann N Y Acad Sci (1996) 0.83
Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells. Clin Exp Immunol (2008) 0.83
Cytokine genetic profile in Whipple's disease. Eur J Clin Microbiol Infect Dis (2012) 0.81
Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease. Int J Colorectal Dis (2002) 0.79
Murine model of oral tolerance. Induction of Fas-mediated apoptosis by blockade of interleukin-12. Ann N Y Acad Sci (1998) 0.78
Interleukin-18 is increased only in a minority of patients with active Crohn's disease. Int J Colorectal Dis (2007) 0.77
To be responsive or not to be responsive, that is the mucosal question. Gastroenterology (1998) 0.76
Non-alcoholic steatohepatitis occurs in celiac disease and is associated with cellular stress. Z Gastroenterol (2013) 0.76
Progress, problems, and perspectives in diagnosis and treatment of Whipple's disease. Clin Exp Med (2004) 0.76
Perioperative adjuvant therapy with infliximab in complicated anal Crohn's disease. Int J Colorectal Dis (2008) 0.76
[Disorders of apoptosis in chronic inflammatory bowel diseases]. Z Gastroenterol (2000) 0.75
The Society for Mucosal Immunology and Nature Publishing Group bring you Mucosal Immunology. Mucosal Immunol (2008) 0.75
[Whipple disease. Formerly dim prognosis--often treatable today]. MMW Fortschr Med (2002) 0.75
[Anti-inflammatory properties of interleukin-10 in human Crohn's disease: much to learn, much to explore]. Z Gastroenterol (2002) 0.75
Current concepts of immunopathogenesis, diagnosis and therapy in Whipple's disease. Curr Med Chem (2006) 0.75
Cutaneous anergy to streptococcal antigens in Whipple's disease. Am J Gastroenterol (1996) 0.75
[Lymphocytes induce transformation of enterocytes into antigen-transporting M cells]. Z Gastroenterol (1998) 0.75
Case report: increase in CD4 lymphocyte counts after splenectomy in HIV-infected patients. Am J Med Sci (1993) 0.75